デフォルト表紙
市場調査レポート
商品コード
1192786

世界の前立腺がん診断薬ソリューション市場

Global Prostate Cancer Diagnostics Solution Market Research Report 2023

出版日: | 発行: QYResearch | ページ情報: 英文 87 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.36円
世界の前立腺がん診断薬ソリューション市場
出版日: 2023年01月24日
発行: QYResearch
ページ情報: 英文 87 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、前立腺がん診断薬ソリューション (Prostate Cancer Diagnostics Solution) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の前立腺がん診断薬ソリューションの市場規模成長率:タイプ別: 2018 VS 2022 VS 2029
    • Tumor Biomarker Tests
    • Imaging
    • Biopsy
    • Other
  • 市場:用途別
    • 世界の前立腺がん診断薬ソリューション 市場 Growth 用途別: 2018 VS 2022 VS 2029
    • Age Below
    • Age 55-75
    • Age Above
  • 調査目的
  • 対象期間
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の前立腺がん診断薬ソリューションの市場展望 (2018-2029)
  • 前立腺がん診断薬ソリューションの市場成長トレンド:地域別
    • 世界の前立腺がん診断薬ソリューション 市場規模:地域別: 2018 VS 2022 VS 2029
    • 前立腺がん診断薬ソリューションの市場規模実績:地域別 (2018-2023)
    • 前立腺がん診断薬ソリューションの市場規模予測:地域別 (2024-2029)
  • 前立腺がん診断薬ソリューション 市場動向
    • 前立腺がん診断薬ソリューション 業界動向
    • 前立腺がん診断薬ソリューション 市場の促進要因
    • 前立腺がん診断薬ソリューション 市場の課題
    • 前立腺がん診断薬ソリューション 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のトップ 前立腺がん診断薬ソリューションの上位企業:収益別
    • 世界のトップ 前立腺がん診断薬ソリューションの上位企業:収益別 (2018-2023)
    • 世界の前立腺がん診断薬ソリューションの収益シェア:企業別 (2018-2023)
  • 世界の前立腺がん診断薬ソリューションの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:前立腺がん診断薬ソリューション 収益
  • 世界の前立腺がん診断薬ソリューション 市場集中度
    • 世界の前立腺がん診断薬ソリューション 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 前立腺がん診断薬ソリューションの収益 2022
  • 前立腺がん診断薬ソリューションの主要企業の本社および事業エリア
  • 主要企業 前立腺がん診断薬ソリューションの製品ソリューションおよびサービス
  • 市場参入時期: 前立腺がん診断薬ソリューション 市場
  • M&A, 拡張計画

第4章 前立腺がん診断薬ソリューション 内訳データ:タイプ別

  • 世界の前立腺がん診断薬ソリューションの市場規模実績:タイプ別 (2018-2023)
  • 世界の前立腺がん診断薬ソリューションの市場規模予測:タイプ別 (2024-2029)

第5章 前立腺がん診断薬ソリューション 内訳データ:用途別

  • 世界の前立腺がん診断薬ソリューションの市場規模実績:用途別 (2018-2023)
  • 世界の前立腺がん診断薬ソリューションの市場規模予測:用途別 (2024-2029)

第6章 北米

  • 北米の前立腺がん診断薬ソリューション 市場規模 (2018-2029)
  • 北米の前立腺がん診断薬ソリューション 市場 成長率 国別: 2018 VS 2022 VS 2029
  • 北米の前立腺がん診断薬ソリューション 市場規模:国別 (2018-2023)
  • 北米の前立腺がん診断薬ソリューション 市場規模:国別 (2024-2029)
  • 米国
  • カナダ

第7章 欧州

  • 欧州の前立腺がん診断薬ソリューション 市場規模 (2018-2029)
  • 欧州の前立腺がん診断薬ソリューション 市場 成長率 国別: 2018 VS 2022 VS 2029
  • 欧州の前立腺がん診断薬ソリューション 市場規模:国別 (2018-2023)
  • 欧州の前立腺がん診断薬ソリューション 市場規模:国別 (2024-2029)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 前立腺がん診断薬ソリューション 市場規模 (2018-2029)
  • アジア太平洋地域 前立腺がん診断薬ソリューション 市場 成長率 地域別: 2018 VS 2022 VS 2029
  • アジア太平洋地域 前立腺がん診断薬ソリューション 市場規模:地域別 (2018-2023)
  • アジア太平洋地域 前立腺がん診断薬ソリューション 市場規模:地域別 (2024-2029)
  • 中国
  • 日本
  • 韓国
  • 東南アジア
  • インド
  • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの前立腺がん診断薬ソリューション 市場規模 (2018-2029)
  • ラテンアメリカの前立腺がん診断薬ソリューション 市場 成長率 国別: 2018 VS 2022 VS 2029
  • ラテンアメリカの前立腺がん診断薬ソリューション 市場規模:国別 (2018-2023)
  • ラテンアメリカの前立腺がん診断薬ソリューション 市場規模:国別 (2024-2029)
  • メキシコ
  • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの前立腺がん診断薬ソリューション 市場規模 (2018-2029)
  • 中東・アフリカの前立腺がん診断薬ソリューション 市場 成長率 国別: 2018 VS 2022 VS 2029
  • 中東・アフリカの前立腺がん診断薬ソリューション 市場規模:国別 (2018-2023)
  • 中東・アフリカの前立腺がん診断薬ソリューション 市場規模:国別 (2024-2029)
  • トルコ
  • サウジアラビア
  • UAE

第11章 主要企業のプロファイル

  • OPKO
  • Genomic Health
  • Abbott
  • Beckman Coulter
  • Siemens Healthcare
  • bioMeriux
  • Roche
  • MDx Health
  • DiaSorin
  • Myriad Genetics
  • Ambry Genetics

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of Tumor Biomarker Tests
  • Table 3. Key Players of Imaging
  • Table 4. Key Players of Biopsy
  • Table 5. Key Players of Other
  • Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
  • Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2018-2023)
  • Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2024-2029)
  • Table 12. Prostate Cancer Diagnostics Solution Market Trends
  • Table 13. Prostate Cancer Diagnostics Solution Market Drivers
  • Table 14. Prostate Cancer Diagnostics Solution Market Challenges
  • Table 15. Prostate Cancer Diagnostics Solution Market Restraints
  • Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2018-2023) & (US$ Million)
  • Table 17. Global Prostate Cancer Diagnostics Solution Market Share by Players (2018-2023)
  • Table 18. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
  • Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2022
  • Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2018-2023)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
  • Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2018-2023) & (US$ Million)
  • Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2018-2023)
  • Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2024-2029)
  • Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2018-2023) & (US$ Million)
  • Table 30. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2018-2023)
  • Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 32. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Application (2024-2029)
  • Table 33. North America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
  • Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
  • Table 36. Europe Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 40. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023) & (US$ Million)
  • Table 41. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029) & (US$ Million)
  • Table 42. Latin America Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 43. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
  • Table 44. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
  • Table 45. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 46. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023) & (US$ Million)
  • Table 47. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029) & (US$ Million)
  • Table 48. OPKO Company Detail
  • Table 49. OPKO Business Overview
  • Table 50. OPKO Prostate Cancer Diagnostics Solution Product
  • Table 51. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 52. OPKO Recent Development
  • Table 53. Genomic Health Company Detail
  • Table 54. Genomic Health Business Overview
  • Table 55. Genomic Health Prostate Cancer Diagnostics Solution Product
  • Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 57. Genomic Health Recent Development
  • Table 58. Abbott Company Detail
  • Table 59. Abbott Business Overview
  • Table 60. Abbott Prostate Cancer Diagnostics Solution Product
  • Table 61. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 62. Abbott Recent Development
  • Table 63. Beckman Coulter Company Detail
  • Table 64. Beckman Coulter Business Overview
  • Table 65. Beckman Coulter Prostate Cancer Diagnostics Solution Product
  • Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 67. Beckman Coulter Recent Development
  • Table 68. Siemens Healthcare Company Detail
  • Table 69. Siemens Healthcare Business Overview
  • Table 70. Siemens Healthcare Prostate Cancer Diagnostics Solution Product
  • Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 72. Siemens Healthcare Recent Development
  • Table 73. bioMeriux Company Detail
  • Table 74. bioMeriux Business Overview
  • Table 75. bioMeriux Prostate Cancer Diagnostics Solution Product
  • Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 77. bioMeriux Recent Development
  • Table 78. Roche Company Detail
  • Table 79. Roche Business Overview
  • Table 80. Roche Prostate Cancer Diagnostics Solution Product
  • Table 81. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 82. Roche Recent Development
  • Table 83. MDx Health Company Detail
  • Table 84. MDx Health Business Overview
  • Table 85. MDx Health Prostate Cancer Diagnostics Solution Product
  • Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 87. MDx Health Recent Development
  • Table 88. DiaSorin Company Detail
  • Table 89. DiaSorin Business Overview
  • Table 90. DiaSorin Prostate Cancer Diagnostics Solution Product
  • Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 92. DiaSorin Recent Development
  • Table 93. Myriad Genetics Company Detail
  • Table 94. Myriad Genetics Business Overview
  • Table 95. Myriad Genetics Prostate Cancer Diagnostics Solution Product
  • Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 97. Myriad Genetics Recent Development
  • Table 98. Ambry Genetics Company Detail
  • Table 99. Ambry Genetics Business Overview
  • Table 100. Ambry Genetics Prostate Cancer Diagnostics Solution Product
  • Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023) & (US$ Million)
  • Table 102. Ambry Genetics Recent Development
  • Table 103. Research Programs/Design for This Report
  • Table 104. Key Data Information from Secondary Sources
  • Table 105. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Type (2023-2029) & (US$ Million)
  • Figure 2. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2022 VS 2029
  • Figure 3. Tumor Biomarker Tests Features
  • Figure 4. Imaging Features
  • Figure 5. Biopsy Features
  • Figure 6. Other Features
  • Figure 7. Global Prostate Cancer Diagnostics Solution Market Size Comparison by Application (2023-2029) & (US$ Million)
  • Figure 8. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2022 VS 2029
  • Figure 9. Age Below 55 Case Studies
  • Figure 10. Age 55-75 Case Studies
  • Figure 11. Age Above 75 Case Studies
  • Figure 12. Prostate Cancer Diagnostics Solution Report Years Considered
  • Figure 13. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 14. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2022 VS 2029
  • Figure 16. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2022
  • Figure 17. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2022)
  • Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2022
  • Figure 19. North America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 20. North America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
  • Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
  • Figure 25. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Region (2018-2029)
  • Figure 33. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 38. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 39. Latin America Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. Latin America Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
  • Figure 41. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Country (2018-2029)
  • Figure 45. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2018-2023)
  • Figure 58. Bottom-up and Top-down Approaches for This Report
  • Figure 59. Data Triangulation
  • Figure 60. Key Executives Interviewed
目次

This research report focuses on the Prostate Cancer Diagnostics Solution Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 Tumor Biomarker Tests
    • 1.2.3 Imaging
    • 1.2.4 Biopsy
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Prostate Cancer Diagnostics Solution Market Growth by Application: 2018 VS 2022 VS 2029
    • 1.3.2 Age Below 55
    • 1.3.3 Age 55-75
    • 1.3.4 Age Above 75
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2018-2029)
  • 2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region
    • 2.2.1 Global Prostate Cancer Diagnostics Solution Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2018-2023)
    • 2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2024-2029)
  • 2.3 Prostate Cancer Diagnostics Solution Market Dynamics
    • 2.3.1 Prostate Cancer Diagnostics Solution Industry Trends
    • 2.3.2 Prostate Cancer Diagnostics Solution Market Drivers
    • 2.3.3 Prostate Cancer Diagnostics Solution Market Challenges
    • 2.3.4 Prostate Cancer Diagnostics Solution Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue
    • 3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2018-2023)
    • 3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2018-2023)
  • 3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue
  • 3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio
    • 3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2022
  • 3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served
  • 3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
  • 3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics Solution Breakdown Data by Type

  • 4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2018-2023)
  • 4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2024-2029)

5 Prostate Cancer Diagnostics Solution Breakdown Data by Application

  • 5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2018-2023)
  • 5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
  • 6.2 North America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 6.3 North America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
  • 6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
  • 6.5 United States
  • 6.6 Canada

7 Europe

  • 7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2018-2029)
  • 7.2 Europe Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
  • 7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
  • 7.5 Germany
  • 7.6 France
  • 7.7 U.K.
  • 7.8 Italy
  • 7.9 Russia
  • 7.10 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2018-2029)
  • 8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
  • 8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2018-2023)
  • 8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2024-2029)
  • 8.5 China
  • 8.6 Japan
  • 8.7 South Korea
  • 8.8 Southeast Asia
  • 8.9 India
  • 8.10 Australia

9 Latin America

  • 9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2018-2029)
  • 9.2 Latin America Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
  • 9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
  • 9.5 Mexico
  • 9.6 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2018-2029)
  • 10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2018-2023)
  • 10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2024-2029)
  • 10.5 Turkey
  • 10.6 Saudi Arabia
  • 10.7 UAE

11 Key Players Profiles

  • 11.1 OPKO
    • 11.1.1 OPKO Company Detail
    • 11.1.2 OPKO Business Overview
    • 11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
    • 11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.1.5 OPKO Recent Development
  • 11.2 Genomic Health
    • 11.2.1 Genomic Health Company Detail
    • 11.2.2 Genomic Health Business Overview
    • 11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
    • 11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.2.5 Genomic Health Recent Development
  • 11.3 Abbott
    • 11.3.1 Abbott Company Detail
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
    • 11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.3.5 Abbott Recent Development
  • 11.4 Beckman Coulter
    • 11.4.1 Beckman Coulter Company Detail
    • 11.4.2 Beckman Coulter Business Overview
    • 11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
    • 11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.4.5 Beckman Coulter Recent Development
  • 11.5 Siemens Healthcare
    • 11.5.1 Siemens Healthcare Company Detail
    • 11.5.2 Siemens Healthcare Business Overview
    • 11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
    • 11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.5.5 Siemens Healthcare Recent Development
  • 11.6 bioMeriux
    • 11.6.1 bioMeriux Company Detail
    • 11.6.2 bioMeriux Business Overview
    • 11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
    • 11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.6.5 bioMeriux Recent Development
  • 11.7 Roche
    • 11.7.1 Roche Company Detail
    • 11.7.2 Roche Business Overview
    • 11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
    • 11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.7.5 Roche Recent Development
  • 11.8 MDx Health
    • 11.8.1 MDx Health Company Detail
    • 11.8.2 MDx Health Business Overview
    • 11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
    • 11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.8.5 MDx Health Recent Development
  • 11.9 DiaSorin
    • 11.9.1 DiaSorin Company Detail
    • 11.9.2 DiaSorin Business Overview
    • 11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
    • 11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.9.5 DiaSorin Recent Development
  • 11.10 Myriad Genetics
    • 11.10.1 Myriad Genetics Company Detail
    • 11.10.2 Myriad Genetics Business Overview
    • 11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
    • 11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.10.5 Myriad Genetics Recent Development
  • 11.11 Ambry Genetics
    • 11.11.1 Ambry Genetics Company Detail
    • 11.11.2 Ambry Genetics Business Overview
    • 11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
    • 11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2018-2023)
    • 11.11.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details